
Antares Pharma, Inc. ATRS
Antares Pharma, Inc. Langfristige Verbindlichkeiten 2011-2026 | ATRS
Langfristige Verbindlichkeiten Jährlich Antares Pharma, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 30.2 M | 45.8 M | 22.1 M | 25.1 M | 1.2 M | 700 K | 3.35 M | 1.86 M | 1.04 M | 810 K |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 45.8 M | 700 K | 13.2 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Instrumente
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
12.9 M | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
1.54 B | $ 61.75 | 0.49 % | $ 12.3 B | ||
|
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | ||
|
ICU Medical
ICUI
|
66.7 M | $ 129.31 | 4.57 % | $ 3.19 B | ||
|
Alcon
ALC
|
6.05 B | $ 67.28 | 1.48 % | $ 40.4 B | ||
|
Intuitive Surgical
ISRG
|
418 M | $ 449.03 | 1.69 % | $ 160 B | ||
|
iRhythm Technologies
IRTC
|
119 M | $ 117.0 | 2.78 % | $ 3.74 B | ||
|
Repro Med Systems
KRMD
|
239 K | $ 4.0 | 1.01 % | $ 185 M | ||
|
LeMaitre Vascular
LMAT
|
19.3 M | $ 101.43 | 0.1 % | $ 2.3 B | ||
|
Cantel Medical Corp.
CMD
|
1.16 B | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
74.1 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
1.99 B | - | -0.05 % | $ 10.3 B | ||
|
Masimo Corporation
MASI
|
56 M | $ 178.79 | -0.01 % | $ 9.53 B | ||
|
Milestone Scientific
MLSS
|
1.4 M | $ 0.4 | 14.99 % | $ 32.8 M | ||
|
Ekso Bionics Holdings
EKSO
|
11.2 M | - | - | $ 28.6 M | ||
|
Varian Medical Systems, Inc.
VAR
|
421 M | - | -0.02 % | $ 16.3 B | ||
|
electroCore
ECOR
|
1.42 M | $ 6.13 | 3.81 % | $ 52 K | ||
|
Envista Holdings Corporation
NVST
|
1.91 B | $ 23.77 | 3.15 % | $ 3.99 B | ||
|
Haemonetics Corporation
HAE
|
405 M | $ 59.56 | 4.79 % | $ 3 B | ||
|
STERIS plc
STE
|
1.53 B | $ 215.97 | 0.67 % | $ 21.3 B | ||
|
Isoray
ISR
|
621 K | - | 0.03 % | $ 108 M | ||
|
Glaukos Corporation
GKOS
|
87.4 M | $ 143.82 | 2.71 % | $ 6.97 B | ||
|
STAAR Surgical Company
STAA
|
12.5 M | $ 33.05 | 1.38 % | $ 1.64 B | ||
|
InfuSystem Holdings
INFU
|
35 M | $ 10.16 | 5.07 % | $ 210 M | ||
|
Microbot Medical
MBOT
|
760 K | $ 1.74 | 0.58 % | $ 79.7 M | ||
|
Teleflex Incorporated
TFX
|
2.77 B | $ 135.18 | 1.81 % | $ 6.03 B | ||
|
Utah Medical Products
UTMD
|
5.25 M | $ 64.17 | 0.27 % | $ 208 M | ||
|
Merit Medical Systems
MMSI
|
626 M | $ 64.49 | 1.13 % | $ 3.82 B | ||
|
West Pharmaceutical Services
WST
|
427 M | $ 305.5 | 0.55 % | $ 22.1 B | ||
|
DENTSPLY SIRONA
XRAY
|
2.54 B | $ 9.84 | 1.03 % | $ 1.96 B | ||
|
Pulse Biosciences
PLSE
|
6.72 M | $ 26.09 | 4.57 % | $ 1.76 B | ||
|
Retractable Technologies
RVP
|
2.38 M | $ 0.66 | -2.35 % | $ 19.8 M | ||
|
Pro-Dex
PDEX
|
9.93 M | $ 63.47 | 4.43 % | $ 209 M | ||
|
Predictive Oncology
POAI
|
236 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
41.7 M | $ 24.0 | 4.12 % | $ 1.15 B | ||
|
Stereotaxis
STXS
|
1.65 M | $ 1.85 | 7.56 % | $ 168 M | ||
|
Baxter International
BAX
|
7.05 B | $ 18.77 | 2.37 % | $ 9.63 B | ||
|
ResMed
RMD
|
1.05 B | $ 209.86 | 0.98 % | $ 30.7 B | ||
|
AtriCure
ATRC
|
261 M | $ 29.0 | 0.69 % | $ 1.38 B | ||
|
Harvard Bioscience
HBIO
|
58.5 M | $ 5.4 | 7.78 % | $ 240 M | ||
|
NeuroMetrix
NURO
|
917 K | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
148 M | $ 11.81 | 3.23 % | $ 482 M | ||
|
Becton, Dickinson and Company
BDX
|
25 B | $ 146.95 | 0.02 % | $ 42.3 B | ||
|
Nephros
NEPH
|
1.61 M | $ 3.57 | -1.79 % | $ 37.9 M | ||
|
OraSure Technologies
OSUR
|
22.5 M | $ 3.07 | -0.32 % | $ 226 M | ||
|
Repligen Corporation
RGEN
|
708 M | $ 111.74 | 2.97 % | $ 6.28 M |